Oncolytics Biotech (TSE:ONC) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Oncolytics Biotech Inc., a clinical-stage biotech firm, will hold a conference call on May 9, 2024, to discuss its Q1 financial results and provide a corporate update. The company, known for developing the immunotherapeutic agent pelareorep for various cancers, has seen promising results in clinical trials and holds Fast Track designation for metastatic breast and pancreatic cancer treatments.
For further insights into TSE:ONC stock, check out TipRanks’ Stock Analysis page.
